Artificial Blood Vessels Market Size, Share, and Growth Forecast for 2024 - 2031

Artificial Blood Vessels Market Size and Share Analysis

The global artificial blood vessels market is projected to witness a CAGR of 4.1% during the forecast period from 2024 to 2031. It is anticipated to increase from US$ 2.1 Bn recorded in 2024 to a staggering US$ 2.9 Bn by 2031.

The market is set to be driven by rising prevalence of cardiovascular diseases, innovations in surgical techniques, and increasing awareness of heart health. Rising aging population and growing demand for minimally invasive procedures further propel market growth.

Innovations in materials and technology, alongside supportive government initiatives, also play a key role in enhancing treatment options. For example, in Europe, the 2024 ESC Guidelines for Peripheral Arterial and Aortic Diseases (PAAD) merged with the 2017 and 2014 guidelines.

The norms focus on atherosclerotic arterial diseases and non-atherosclerotic genetic conditions. These provide a comprehensive framework for healthcare professionals, emphasizing patient-centered care, preventive strategies, and recommendations.   

Key Highlights of the Market

• North America is expected to rise at a CAGR of 5.9% during the forecast period amid increasing prevalence of coronary and peripheral artery disease.
• The market in Asia Pacific is projected to surge at a CAGR of 7.5% through 2031 due to rising cases of hypertension and cardiovascular diseases.
• By application, the peripheral artery disease segment is expected to witness a CAGR of 5.8% during the forecast period owing to innovations in minimally invasive surgical techniques.
• By polymer type, the polyethylene terephthalate segment is projected to surge at a CAGR of 7.1% through 2031 amid innovations in bioengineered materials that mimic natural blood vessel properties.
• Ongoing research into 3D printing is anticipated to enhance the customization of vascular implants.
• Trend toward personalized medicine in vascular treatments is gaining momentum worldwide.

Market Attributes	Key Insights
Market Size (2024E)	US$ 2.1 Bn
Projected Market Value (2031F)	US$ 2.9 Bn
Global Market Growth Rate (CAGR 2024 to 2031)	4.1%
Historical Market Growth Rate (CAGR 2019 to 2023)	3.6%

North America Artificial Blood Vessels Market Leads with Initiatives by CDC

North America is set to dominate the artificial blood vessels materials industry in 2024, rising at a CAGR of 5.9% during the forecast period. The region is grappling with a surging mortality rate from aortic aneurysms as well as increasing cases of peripheral and coronary artery diseases. These alarming trends are prompting higher awareness about heart health through various programs and initiatives. For example,

• The Centers for Disease Control and Prevention (CDC) reported that about 9,904 deaths in the U.S. in 2019 were due to aortic aneurysms, with men accounting for 59% of those fatalities.

CDC runs several programs as the aforementioned deaths could potentially be prevented with timely surgical interventions. The organization promotes the use of artificial blood vessels, underscoring the critical need for innovations in this field.

The combination of high disposable incomes, an advanced healthcare infrastructure, and the presence of leading industry players fuels product development and innovation. With these factors in play, the artificial blood vessels industry in North America is poised for notable growth from 2024 to 2031.

Asia Pacific to See High Demand as Number of Cardiac Procedures Rises

The artificial blood vessels market in Asia Pacific is set to rise at 7.5% CAGR through 2031. This surge is largely driven by a notable increase in the number of individuals dealing with cardiovascular diseases and hypertension. In addition, rising demand for cardiovascular surgeries is anticipated to push growth. For example,

• A report published in April 2023 indicated that nearly 300,000 cardiac procedures are performed annually in India alone.

The growing need for surgical interventions highlights the increasing demand for artificial blood vessels in the region. Several research institutions are investing huge sums in research and development activities to discover novel products. For example,

• In August 2024, the Indian Institute of Science (IISc) developed artificial blood vessels that closely resemble real ones. These can be used as grafts or replacements for blocked, injured, or damaged blood vessels.  

Polyethylene Terephthalate Gains Traction due to Rising Surgical Interventions

Category	CAGR through 2031
Polymer Type- Polyethylene Terephthalate	7.1%

In the global market, Polyethylene Terephthalate (PET) is the leading segment in terms of polymer type. This material is favored for its excellent mechanical properties, biocompatibility, and resistance to degradation, making it ideal for vascular applications.

The PET segment is projected to be further driven by the increasing prevalence of cardiovascular diseases and the rising demand for effective surgical interventions. For instance,

• The Centers for Disease Control and Prevention (CDC) reported that cardiovascular diseases accounted for about 697,000 deaths in the U.S. in 2020. This highlights the urgent need for unique medical solutions like artificial blood vessels made from PET.

The growing awareness and rising demand for effective treatments are anticipated to propel the market for artificial blood vessels in the coming years.

Non-invasive Procedures to Enhance Treatment of Peripheral Artery Disease

Category	CAGR through 2031
Application- Peripheral Artery Disease	5.8%

By application, the peripheral artery disease or PAD segment is projected to remain dominant through 2031. This growth is driven by the increasing prevalence of PAD, particularly among the aging population, and innovations in minimally invasive surgical techniques that enhance treatment options.

Government initiatives promoting awareness and screening for PAD are set to lead to early diagnoses and increased demand for artificial blood vessels. According to CDC, around 8.5 million adults in the U.S. are affected by PAD, highlighting the significant need for effective treatment solutions. Keeping this in mind, several companies are developing innovative solutions. For example,

• Royal Philips enrolled the first patient in the U.S. THOR IDE clinical trial. It will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips. The device integrates two critical PAD treatments into a single device, simplifying workflows and procedures.

Market Introduction and Trend Analysis

The artificial blood vessels market is experiencing good growth. This expansion is driven by innovations in biotechnology and increasing prevalence of cardiovascular diseases. As the global population rises, demand for vascular grafts and substitutes is surging. This pushes development of innovative solutions to enhance patient outcomes.

Key trends include the development of bioengineered materials that mimic natural blood vessel properties, improving biocompatibility and reducing complications. The rise of minimally invasive surgical techniques is propelling the adoption of synthetic blood vessels. This trend is driven by their short recovery times and low risk of infection.

Ongoing research into 3D printing technologies is also anticipated to boost the customization of vascular implants. This trend will likely address individual patient needs and foster personalized medicine in vascular treatments.

Historical Growth and Course Ahead

The artificial blood vessels market showed steady growth at a CAGR of 3.6% from 2019 to 2023. This period was characterized by increased awareness of cardiovascular health, leading to a rising demand for vascular grafts and implants.

Key innovations in materials and manufacturing processes contributed greatly to this growth. Healthcare providers also sought solutions to improve patient outcomes and reduce surgical complications.

The market is projected to accelerate further, with a considerable CAGR of 4.1% from 2024 to 2031. This upward trajectory is fueled by developments in biotechnology, the rise of personalized medicine, and a growing elderly population susceptible to vascular diseases. For example,

• In January 2023, Nicolas L'Heureux, director of the Tissue Bioengineering Laboratory in Bordeaux, designed artificial vessels that are impermeable, resistant, and contain no synthetic products. He used a freeze-drying technique to compress collagen, treat it to increase its density, and roll it to form a tube for grafting living cells.

The integration of 3D printing technology and bioengineered materials is poised to transform the landscape. It will likely enhance the efficacy and customization of artificial blood vessels, ultimately driving market expansion and improving patient care in the next ten years.

Market Growth Drivers

Increasing Cases of Cardiovascular Diseases to Foster Demand

Rising incidence of cardiovascular diseases is a significant growth driver for the artificial blood vessels market. For example,

• As per the National Institute of Health, about 82.6 million people in the U.S. are currently living with one or more forms of cardiovascular disease (CVD). This shows the rising demand for artificial blood vessels.

Factors such as sedentary lifestyles, unhealthy eating habits, and an aging population contribute to the prevalence of conditions like atherosclerosis and coronary artery disease. As these health issues become more widespread, demand for effective treatment options, including vascular grafts and artificial blood vessels, rises.

Rising Demand for Minimally Invasive Surgical Techniques to Boost Innovations

Growing preference for minimally invasive surgical procedures is another key driver of the global market. Patients and healthcare providers alike are seeking alternatives to traditional open surgeries due to the associated risks and longer recovery times.

Artificial blood vessels facilitate minimally invasive approaches, allowing for quicker procedures with reduced postoperative complications. As surgical techniques evolve, adoption of artificial grafts becomes increasingly prevalent, leading to a surging demand.

Researchers and companies focus on developing artificial blood vessels using the latest technologies, thereby fostering market growth. For example,

• In July 2024, researchers from the University of Edinburgh and Heriot-Watt University developed artificial blood vessels using 3D printing technology to improve the treatment of cardiovascular diseases (CVD). These grafts are as strong as natural blood vessels and can reduce scarring, pain, and infection risks associated with human vein removal in bypass operations.

Market Restraining Factors

High Costs of Production and Implementation to Decline Demand

One of the significant factors impeding the artificial blood vessels industry is the high costs associated with the production and implementation of these unique medical devices. The manufacturing processes often involve novel technologies and materials, which can lead to high prices for both healthcare providers and patients.

The financial barrier may limit accessibility, particularly in developing regions where healthcare budgets are constrained. As a result, the adoption of artificial blood vessels may be slower, hindering market growth.

Long Approval Processes Involving Strict Norms May Hinder Growth

Regulatory challenges pose another obstacle to the global market. The approval processes for medical devices can be lengthy and complex, requiring extensive clinical trials and compliance with stringent safety standards.

Evolving regulatory hurdles can delay the introduction of innovative products, limiting the market's responsiveness to emerging needs and technological developments. The variability in regulations across different regions can complicate market entry for manufacturers, further impeding growth and innovation in the artificial blood vessels business.

Key Market Opportunities

Personalized Medicine and Customization Trends to Create New Opportunities

The future of the global market holds significant opportunities through the innovation of personalized medicine. As healthcare shifts toward tailored treatment approaches, the ability to customize artificial blood vessels to meet individual patient needs is becoming increasingly feasible.

Innovations in 3D printing technology allow for the creation of bespoke vascular grafts that match a patient's anatomical specifications and biological requirements. For example,

• As per the National Institutes of Health (NIH), researchers are developing bioengineered vascular constructs and functional blood vessels using living cells and biocompatible materials. This is projected to revolutionize personalized regenerative medicine by treating vascular diseases at their root cause.  

As personalized healthcare gains traction, demand for customized vascular solutions is set to surge, driving market growth.

Emergence of 3D Printing and Bioengineered Materials to Foster Opportunities

Technological innovations in manufacturing processes are revolutionizing the global market. Innovations such as 3D printing and the development of bioengineered materials enable the production of customized vascular implants. These closely mimic the properties of natural blood vessels. These developments not only improve biocompatibility but also enhance the durability and functionality of artificial grafts.

The integration of smart materials that respond to physiological changes offers new avenues for improved patient outcomes. For example,

• In May 2024, researchers at the University of Hong Kong developed a new fluidic system called VasFluidics, inspired by the vascular network. VasFluidics has promising applications, especially for designing microtubule structures and bioinks. It has the potential to be combined with cell engineering for biomedical applications, such as organ-on-chip and organoids.

As similar innovations continue to rise, the market is likely to witness an influx of innovative products, further driving growth.

Competitive Landscape for the Artificial Blood Vessels Market

The competitive landscape of the synthetic blood vessels market is characterized by rapid innovation and strategic collaborations among key players. Companies are focusing on developing cutting-edge products that enhance patient outcomes and address specific medical needs.

Japan-based Terumo Corporation, for instance, has launched several innovative products, including a new line of bioengineered vascular grafts. These are designed to improve biocompatibility and reduce the risk of complications. These innovations not only strengthen Terumo's market position but also reflect the broader trend of integrating cutting-edge technology into vascular solutions. As competition intensifies, companies are likely to invest heavily in research and development to maintain their edge in this booming market.

Recent Industry Developments

• In October 2024, KIMSHEALTH Hospital, Trivandrum, Kerala, opened a state-of-the-art electrophysiology lab with advanced 3D mapping technology. The lab aims to bridge the gap between engineering and medicine. The ENSITE X 3D omnipolar mapping system enables precise identification, mapping, and targeting of abnormal electrical activities in the blood vessels of the heart.
• In October 2024, researchers at University College London developed a 3D photoacoustic scanner to speed up vascular imaging for real-time clinical use. The technology aims to visualize microvasculature to sub-centimeter depths, which is crucial for effective clinical management of vascular abnormalities.
• In May 2024, a team of engineers at Carnegie Mellon University developed a new method to create artificial blood vessels. The new method could potentially support lab-made organs, test new medicines, and even replace damaged vessels in individuals with cardiovascular disease.

Artificial Blood Vessels Industry Report Scope

Attributes	Details
Forecast Period	2024 to 2031
Historical Data Available for	2019 to 2023
Market Analysis	US$ Billion for Value
Key Regions Covered	North America  Europe  East Asia  South Asia and Oceania  Latin America  Middle East and Africa
Key Market Segments Covered	Polymer Type   Application  End User  Region
Key Companies Profiled in the Report	Braun Melsungen Becton Dickinson and Company  Cook Medical Incorporated  Medtronic  LeMaitre Vascular Inc.  Terumo Medical Corporation  W. L. Gore and Associates  Jotec GmbH  Humacyte Inc.  Techshot Inc.
Report Coverage	Market Forecast and Trends Company Share Analysis Competitive Intelligence DROT Analysis Market Dynamics and Challenges Strategic Growth Initiatives
Customization and Pricing	Available upon request

Artificial Blood Vessels Industry Segmentation

By Polymer Type

• Polydioxanone 
• Elastomer 
• Polyethylene Terephthalate 
• Others  

By Application 

• Aortic Disease 
• Peripheral Artery Disease 
• Hemodialysis 

By End User

• Hospitals 
• Cardiac Catheterization Laboratories 
• Ambulatory Surgical Centers 
• Specialty Clinics 
• Others 

By Region

• North America 
• Europe 
• East Asia 
• South Asia and Oceania 
• Latin America 
• Middle East and Africa 

To know more about delivery timeline for this report Contact Sales